Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $32.1 million versus the consensus estimate of $31.5 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.